We are live on ! Find out more
EFG

Ethos Financial Group Portfolio holdings

AUM $1.37B
1-Year Est. Return 19.43%
This Fund
S&P 500
This Quarter Est. Return
+2.37%
1 Year Est. Return
+19.43%
3 Year Est. Return
+49.7%
5 Year Est. Return
10 Year Est. Return
AUM
$1.35B
AUM Growth
+$79.3M
Cap. Flow
+$60.5M
Cap. Flow %
4.47%
Top 10 Hldgs %
25.68%
Holding
587
New
76
Increased
168
Reduced
211
Closed
55

Sector Composition

Rank Sector Weight
1 Technology 5.12%
2 Financials 4.58%
3 Communication Services 2.54%
4 Consumer Discretionary 1.84%
5 Utilities 1.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PSB.PRX
451
DELISTED
PS Business Parks, Inc. Depositary Shares Each Representing 1/1,000 of a Share of 5.25 Percent Cumulative Preferred Stock, Series X
PSB.PRX
$114K 0.01%
11,533
-117
-1% -$1.16K
SELF
452
Global Self Storage
SELF
$58.1M
$111K 0.01%
21,810
-3,830
-15% -$19.2K
MMT
453
Aberdeen Multi-Market Income Fund
MMT
$238M
$111K 0.01%
23,772
PSEC icon
454
Prospect Capital
PSEC
$1.12B
$105K 0.01%
40,459
-2,376
-6% -$6.35K
CTMX icon
455
CytomX Therapeutics
CTMX
$701M
$101K 0.01%
23,697
NMAD
456
Nomad Power Solutions
NMAD
$81M
$97.5K 0.01%
24,808
PPT
457
Franklin Premier Income Trust
PPT
$323M
$93.9K 0.01%
26,526
CMPS
458
Compass Pathways
CMPS
$1.46B
$93.4K 0.01%
13,532
+1,224
+10% +$7.46K
PLUG icon
459
Plug Power
PLUG
$2.73B
$83.9K 0.01%
42,607
OXSQ icon
460
Oxford Square Capital
OXSQ
$147M
$73.9K 0.01%
41,967
-5,124
-11% -$9.32K
WDH
461
Waterdrop
WDH
$413M
$73K 0.01%
+38,401
New +$68.4K
ORGO icon
462
Organogenesis Holdings
ORGO
$326M
$67.3K 0.01%
+12,987
New +$62.9K
AREC icon
463
American Resources Corp
AREC
$184M
$65.6K ﹤0.01%
26,464
RXRX icon
464
Recursion Pharmaceuticals
RXRX
$1.62B
$53.3K ﹤0.01%
+13,020
New +$64.5K
HIVE
465
HIVE Digital Technologies
HIVE
$760M
$51.6K ﹤0.01%
20,000
FCO
466
DELISTED
abrdn Global Income Fund
FCO
$40.1K ﹤0.01%
13,722
-1,661
-11% -$4.86K
SUIG
467
Sui Group Holdings
SUIG
$73M
$38.9K ﹤0.01%
+23,282
New +$60.2K
ZN
468
DELISTED
Zion Oil & Gas, Inc.
ZN
$34.3K ﹤0.01%
158,613
NRXP icon
469
NRX Pharmaceuticals
NRXP
$152M
$32.2K ﹤0.01%
11,900
SURG icon
470
SurgePays
SURG
$6.03M
$21.5K ﹤0.01%
12,867
-35,887
-74% -$79.9K
NWBO
471
DELISTED
Northwest Biotherapeutics, Inc. Common stock
NWBO
$6.49K ﹤0.01%
28,350
+3,000
+12% +$686
FBLG icon
472
FibroBiologics
FBLG
$3.95M
$5.49K ﹤0.01%
1,221
ALC icon
473
Alcon
ALC
$33.7B
-3,192
Closed -$238K
ATH.PRA
474
Athene Holding Ltd Series A
ATH.PRA
$824M
-8,000
Closed -$204K
BAC.PRK icon
475
Bank of America Depository Shares Series HH
BAC.PRK
$820M
-8,000
Closed -$201K

Similar funds

Ethos Financial Group's Q4 2025 Portfolio in Review

As of Q4 2025, Ethos Financial Group held 587 positions worth $1.35B, up 6.2% from $1.27B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Ethos Financial Group deployed $60.5M of net new capital in Q4 2025, opening 76 new positions and adding to 168 existing holdings. Its largest new stake was Principal Exchange-Traded Funds Principal US Mega-Cap ETF: 111,872 shares worth $7.66M.

By sector, the portfolio is most concentrated in Technology at 5.1% of assets, up from 4.8% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was Janus Henderson B-BBB CLO ETF, an estimated $11M trimmed.

  • Ethos Financial Group's largest Q4 2025 buy was Principal Exchange-Traded Funds Principal US Mega-Cap ETF: 111,872 shares worth $7.66M.
  • Ethos Financial Group added most to iShares S&P 100 ETF in Q4 2025, an estimated $8.22M increase.
  • Ethos Financial Group's biggest Q4 2025 reduction was Janus Henderson B-BBB CLO ETF, cutting an estimated $11M.
  • Ethos Financial Group fully exited iShares Russell Top 200 Growth ETF in Q4 2025, selling an estimated $8.21M.
  • Ethos Financial Group's ten largest holdings make up 26% of its $1.35B portfolio in Q4 2025.
  • Ethos Financial Group opened 76 new positions and closed 55 in Q4 2025.
  • Ethos Financial Group's portfolio value rose 6.2% quarter-over-quarter to $1.35B.

Based on Ethos Financial Group's 13F filing for Q4 2025, filed 20 Jan 2026.